Our Scientific and Medical Board of Advisors

OUR Scientific and Medical Board of Advisors

We are guided by science as we continue to develop stem cell processing and storage methods that yield the best results for patients. Our scientific advisors are leaders in their professions.

Dr. Asawari (Asa) Bapat

Asawari (Asa) is a highly accomplished Medical Doctor (MBBS) with a specialization in Clinical Pathology (DPB), focusing on Transfusion, Transplants, Cellular Therapies, Gene Therapies, Lab Medicine, and Immunology. With over 20 years of leadership experience, Asa has managed projects and facilities including complex Diagnostic labs, hospitals, and facilities for Apheresis, Transfusion medicine, and Regenerative Medicine. She has successfully piloted and spearheaded labs, Cord Blood Banks, Gene and Cellular Therapy Facilities, and Companies towards success, making her a validated global expert in Cellular, tissue, and gene therapies.

Asa serves as a principal investigator, consultant, medical director, and subject matter expert for INDs, IRBs, ATMPs, Clinical Trials in Regenerative Medicine Therapies and Devices, Global Regulatory Compliance, International Quality Management Systems, cGMP, cGLP, cGTP compliance, Gap Audits, Internal and External Audits, Supplier Evaluations, and successfully executing projects internationally. She excels in evaluating technologies, managing technology transfer, conducting risk assessments and management, obtaining Accreditations and Certifications (AABB, AATB, FACT, JCI, CAP, ISO, US FDA, DCGI, MOHAP, and global regulations), and conducting Training and Medical Education as a Subject Matter Expert.

Among her career highlights, Asa has been a member of CTSCC (Cell Therapy Subsection Coordinating Committee), International Variance Committee, Quality, Cord Blood Banking, at AABB (American Association of Blood Banks) representing global experts for Cell and Gene Therapy. She has also been an international-ambassador of AABB for Cellular Therapies (Cell, Tissue, and Gene) since 2015, an advisor to Parents guide to cord blood foundation, Maryland, USA, since 2014, an advisor to Regenerative Outcomes, LLC, Nashville, TN, USA since 2018, and an International Faculty for the Stem Cell Group of India (for regulations and advocacy of stem cells in India).

Asa has been instrumental in laying down Cord Blood banking and Stem Cell Banking regulations in India associated with DCGI, ICMR India, and serves as a consultant for DHCR (Dubai Healthcare City), Dubai Health authority, Ministry of Health, UAE. She is a sought-after speaker, moderator, committee member at international conferences and meetings, and has international publications in Journals of significance. As a Medical Consultant, she provides expertise to Biotech, Pharmaceutical, and Regenerative Medicine Facilities and Companies Globally.

She serves as Chair of Standards Evaluation for International Variance, Co-chair Asia Pacific group and Quality and Regulatory Management, member of Regulatory Affairs Committee that Liaisons with FDA, EU and other regulatory bodies around the world.

Vaxdesign Sanofi Pasteur

Dr. Scott E. Faulkner, MD

Dr. Scott Faulkner is a world-leading stem cell therapy provider, U.S. Air Force veteran, and internal medicine specialist dedicated to enhancing America’s healthcare system. His approach focuses on addressing the root causes of health issues rather than just providing temporary solutions.

At Castle Rock Regenerative Healthcare, Dr. Faulkner utilizes high-quality umbilical cord-derived stem cells to deliver personalized and preventative care, achieving remarkable results in treating over 60 disorders, including Alzheimer’s, arthritis, and autoimmune diseases.

Kevin Kong

Kevin Kong, PharmD, serves as the COO & President of New Frontier Bio, a consumer health company dedicated to identifying, optimizing, and commercializing natural compounds for human health and longevity using biopharma and biotech principles. The company focuses on developing new molecular combinations inspired by nature, which synergistically activate our biological potential, reverse aging signs, and enhance natural health and lifespan at a cellular level. New Frontier Bio’s products are grounded in rigorous scientific, biotechnological, and pharmaceutical standards.

Kevin Kong is also a successful biotech investor, with notable returns such as Turning Point Therapeutics (20x return), and has operated and owned healthcare services companies like Rosewood Rehab.

With a background in Oncology Research from the University of California, Kevin holds a PharmD from the University of the Pacific, graduating at the age of 21. His expertise lies in Clinical Development, Regulatory Affairs, and Business Development within the Healthcare, Biotechnology, and Cosmetics industries.

Dr. Sara Irrgang, M.D.

Dr. Sara Irrgang, M.D., completed her medical education at the Medical College of South Carolina and has a Bachelor of Science degree in Pharmacy from the University of South Carolina. She served in the United States Navy 1915 Ensign Program during the last two years of Medical School, completing a clerkship at the Naval Hospital at Charleston, South Carolina, and a research clerkship at the Naval Aerospace Institute at Pensacola, Florida.

Dr. Irrgang completed her Pathology residency at Baylor University Medical Center and her internship at the University District Hospital, Rio Piedras in San Juan, Puerto Rico. Currently, she is Board Certified in Anatomic and Clinical Pathology and licensed in South Carolina, Texas, New Jersey, and Florida. Dr. Irrgang serves as an Associate Medical Examiner at the District Nine Medical Examiners Office and is a fellow of several organizations, including The College of American Pathologists, National Association of Medical Examiners, Florida Association of Medical Examiners, Seminole County Medical Society, and the Florida Medical Society. She has a passion for breeding show horses and is a 4-H leader in Lake County, Florida.

Dr. Rajendran (Rajen) Naidoo

Dr Naidoo is a physician scientist with a doctorate in Medicine from Yale University and biomedical engineering degrees. His 30 year history in the biosciences with significant research and publications coupled with Orthopedic Surgical training at Albert Einstein College of Medicine uniquely equips him to be a leading clinician today. 

Attention to detail and a profound understanding of how the body moves and functions over time enables Dr Naidoo to help his patients heal from their injuries, improve their quality of life and return to a lifestyle they once enjoyed.

Dr Naidoo collaborates with cutting edge pharmaceutical companies focused on cellular and regenerative medicine as a consultant and also served as Chief Medical Officer of several companies.

Dr Naidoo is an invited lecturer on cellular therapy at prestigious academic institutions worldwide and educates physicians on cellular therapy as well as host an international scientific Cellular Therapy Conference annually.

After a career teaching orthopedic surgery in NYC at Mt Sinai School of Medicine, Dr Naidoo relocated to Florida and established an orthopedic concierge practice in Palm Beach at which location he takes care of US an international patients with clinics and research labs in Hong Kong, Dubai and Abudhabi. Dr Naidoo maintains an active Research collaboration at Harvard University at the Dean center for Tick Borne diseases. Dr Naidoo is the Global Chief Medical officer of World Biotech Inc in Hong Kong and Integrative Medical Health and Wellness Clinics, USA.

Dr Naidoo is a native of South Africa and in his early years proudly served the revolutionary army of Nelson Mandela in South Africa’s struggle for Freedom

Dr. Navin


January 17, 2022

What is a 5-compartment cord blood freezer bag? Historically, cord blood was stored in a cryo-bag with only one or two chambers. Using a one chamber bag requires all of the stored product to be used at one time. A two-chamber bag typically has 80% in one section and 20% in the other section and […]

October 29, 2021

Cord for Life® ANNOUNCES CORD BLOOD CLINICAL TRIAL Phase I Trial for the Treatment of lower back pain of the Sacroiliac Joint ALTAMONTE SPRINGS, FL (October 29, 2021) Cord for Life®, a full-service cord blood bank with over 25 years of experience, today announced plans to conduct a clinical trial to treat lower back pain arising from the Sacroiliac Joint (SIJ) using a biological therapeutic derived from umbilical cord blood.  The company has […]

August 27, 2020

The results of a Phase I study published in Stem Cell Translational Medicine suggest that it is safe and feasible to infuse stem cells from banked umbilical cord blood into adults following an acute ischemic stroke. This research paves the way for additional studies into the efficacy of umbilical cord blood in treating stroke patients. […]

Aspect image
Aspect image
Aspect image
Aspect image
Aspect image

Ready to sign-up for cord blood banking?

Reserve your Cord Blood Collection Kit in time to bring it with you when you go into labor.  Give your newborn every advantage with cord blood banking!

Enroll Today

Donate Cord Blood

By donating your newborn’s cord blood, you are joining a nationwide effort to create a genetically diverse inventory of stem cells for transplant to a child.

Donate Today


Our purpose is to provide the expectant mothers with information necessary to discover the lifesaving potential of umbilical cord blood.

Copyright Cord for Life 2019. All rights reserved.

Skip to content